Literature DB >> 33073264

Increased tumour burden alters skeletal muscle properties in the KPC mouse model of pancreatic cancer.

Ravneet Vohra1, Matthew D Campbell1, Joshua Park1, Stella Whang2, Kayla Gravelle2, Yak-Nam Wang3, Joo-Ha Hwang4, David J Marcinek1, Donghoon Lee1.   

Abstract

BACKGROUND: Cancer cachexia is a multifactorial wasting syndrome that is characterized by the loss of skeletal muscle mass and weakness, which compromises physical function, reduces quality of life, and ultimately can lead to mortality. Experimental models of cancer cachexia have recapitulated this skeletal muscle atrophy and consequent decline in muscle force generating capacity. We address these issues in a novel transgenic mouse model Kras, Trp53 and Pdx-1-Cre (KPC) of pancreatic ductal adenocarcinoma (PDA) using multi-parametric magnetic resonance (mp-MR) measures.
METHODS: KPC mice (n = 10) were divided equally into two groups (n = 5/group) depending on the size of the tumor i.e. tumor size <250 mm3 and >250 mm3. Using mp-MR measures, we demonstrated the changes in the gastrocnemius muscle at the microstructural level. In addition, we evaluated skeletal muscle contractile function in KPC mice using an in vivo approach.
RESULTS: Increase in tumor size resulted in decrease in gastrocnemius maximum cross sectional area, decrease in T2 relaxation time, increase in magnetization transfer ratio, decrease in mean diffusivity, and decrease in radial diffusivity of water across the muscle fibers. Finally, we detected significant decrease in absolute and specific force production of gastrocnemius muscle with increase in tumor size.
CONCLUSIONS: Our findings indicate that increase in tumor size may cause alterations in structural and functional parameters of skeletal muscles and that MR parameters may be used as sensitive biomarkers to noninvasively detect structural changes in cachectic muscles.

Entities:  

Keywords:  Cachexia; Diffusion tensor imaging (DTI); Magnetic resonance imaging (MRI); Magnetization transfer ratio (MTR); Transverse relaxation time (T2)

Year:  2020        PMID: 33073264      PMCID: PMC7566781          DOI: 10.1002/rco2.13

Source DB:  PubMed          Journal:  JCSM Rapid Commun        ISSN: 2617-1619


  69 in total

1.  Different effects of exercise and edema on T2 relaxation in skeletal muscle.

Authors:  L L Ploutz-Snyder; S Nyren; T G Cooper; E J Potchen; R A Meyer
Journal:  Magn Reson Med       Date:  1997-05       Impact factor: 4.668

2.  Magnetic Resonance Monitoring of Disease Progression in mdx Mice on Different Genetic Backgrounds.

Authors:  Ravneet Vohra; Abhinandan Batra; Sean C Forbes; Krista Vandenborne; Glenn A Walter
Journal:  Am J Pathol       Date:  2017-09       Impact factor: 4.307

3.  DTI-based assessment of ischemia-reperfusion in mouse skeletal muscle.

Authors:  Anneriet M Heemskerk; Maarten R Drost; Glenda S van Bochove; Matthijs F M van Oosterhout; Klaas Nicolay; Gustav J Strijkers
Journal:  Magn Reson Med       Date:  2006-08       Impact factor: 4.668

Review 4.  Magnetization transfer imaging: practical aspects and clinical applications.

Authors:  S D Wolff; R S Balaban
Journal:  Radiology       Date:  1994-09       Impact factor: 11.105

5.  Magnetisation transfer ratio of normal brain white matter: a normative database spanning four decades of life.

Authors:  N C Silver; G J Barker; D G MacManus; P S Tofts; D H Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-03       Impact factor: 10.154

6.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

7.  Quantitative magnetization transfer in in vivo healthy human skeletal muscle at 3 T.

Authors:  Christopher D J Sinclair; Rebecca S Samson; David L Thomas; Nikolaus Weiskopf; Antoine Lutti; John S Thornton; Xavier Golay
Journal:  Magn Reson Med       Date:  2010-07-27       Impact factor: 4.668

8.  Adipose tissue fibrosis in human cancer cachexia: the role of TGFβ pathway.

Authors:  Michele Joana Alves; Raquel Galvão Figuerêdo; Flavia Figueiredo Azevedo; Diego Alexandre Cavallaro; Nelson Inácio Pinto Neto; Joanna Darck Carola Lima; Emidio Matos-Neto; Katrin Radloff; Daniela Mendes Riccardi; Rodolfo Gonzalez Camargo; Paulo Sérgio Martins De Alcântara; José Pinhata Otoch; Miguel Luiz Batista Junior; Marília Seelaender
Journal:  BMC Cancer       Date:  2017-03-14       Impact factor: 4.430

9.  Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia.

Authors:  Kate T Murphy; Annabel Chee; Jennifer Trieu; Timur Naim; Gordon S Lynch
Journal:  Dis Model Mech       Date:  2012-03-22       Impact factor: 5.758

10.  Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies.

Authors:  L Politano; V Nigro; G Nigro; V R Petretta; L Passamano; S Papparella; S Di Somma; L I Comi
Journal:  JAMA       Date:  1996-05-01       Impact factor: 56.272

View more
  1 in total

1.  Inflammation and Wasting of Skeletal Muscles in Kras-p53-Mutant Mice with Intraepithelial Neoplasia and Pancreatic Cancer-When Does Cachexia Start?

Authors:  Wulf Hildebrandt; Jan Keck; Simon Schmich; Gabriel A Bonaterra; Beate Wilhelm; Hans Schwarzbach; Anna Eva; Mirjam Bertoune; Emily P Slater; Volker Fendrich; Ralf Kinscherf
Journal:  Cells       Date:  2022-05-11       Impact factor: 7.666

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.